BRAINPATH

Molecular Imaging of Brain Pathophysiology

Coordinatore	PERCUROS BV    more  Organization address address: PLESMANLAAN 1 city: LEIDEN postcode: 2333 BZ contact info Titolo: Mr. Nome: Robbert Cognome: Van Der Zande Email: send email Telefono: +31 487 53 10 79 Fax: +31 487 53 13 66
Nazionalità Coordinatore	Netherlands [NL]
Totale costo	3˙329˙539 €
EC contributo	3˙329˙539 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2013-IAPP
Funding Scheme	MC-IAPP
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-10-01   -   2017-09-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	PERCUROS BV  Organization address address: PLESMANLAAN 1 city: LEIDEN postcode: 2333 BZ contact info Titolo: Mr. Nome: Robbert Cognome: Van Der Zande Email: send email Telefono: +31 487 53 10 79 Fax: +31 487 53 13 66	NL (LEIDEN)	coordinator	1˙081˙553.10
2	UNIVERSITEIT ANTWERPEN  Organization address address: PRINSSTRAAT 13 city: ANTWERPEN postcode: 2000 contact info Titolo: Prof. Nome: Annemie Cognome: Van Der Linden Email: send email Telefono: +323 265 2774	BE (ANTWERPEN)	participant	432˙300.00
3	ACADEMISCH ZIEKENHUIS LEIDEN  Organization address address: Albinusdreef 2 city: LEIDEN postcode: 2333 ZA contact info Titolo: Mr. Nome: Jaco Cognome: De Graaf Email: send email Telefono: +31 71 526 5150	NL (LEIDEN)	participant	367˙025.56
4	TECHNISCHE UNIVERSITAET MUENCHEN  Organization address address: Arcisstrasse 21 city: MUENCHEN postcode: 80333 contact info Titolo: Prof. Nome: Vasilis Cognome: Ntziachristos Email: send email Telefono: +4989 31873852 Fax: 498932000000	DE (MUENCHEN)	participant	353˙664.53
5	MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.  Organization address address: Hofgartenstrasse 8 city: MUENCHEN postcode: 80539 contact info Titolo: Prof. Nome: Mathias Cognome: Hoehn Email: send email Telefono: +49 2214726315 Fax: +49 2214726337	DE (MUENCHEN)	participant	330˙506.44
6	STICHTING VOOR FUNDAMENTEEL ONDERZOEK DER MATERIE - FOM  Organization address address: Van Vollenhovenlaan 659 city: UTRECHT postcode: 3527 JP contact info Titolo: Prof. Nome: Ron Cognome: Heeren Email: send email Telefono: +31 207547100 Fax: +31 207547290	NL (UTRECHT)	participant	299˙866.28
7	MEDRES-MEDICAL RESEARCH GMBH  Organization address address: GLEUELER STRASSE 50 city: KOLN postcode: 50931 contact info Titolo: Dr. Nome: Stefan Cognome: Wecker Email: send email Telefono: +49221 4726 283	DE (KOLN)	participant	276˙975.60
8	ICOMETRIX NV  Organization address address: TERVUURSESTEENWEG 244 city: LEUVEN postcode: 3001 contact info Titolo: Dr. Nome: Dirk Cognome: Smeets Email: send email Telefono: +32 16849697	BE (LEUVEN)	participant	187˙647.90

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'BRAINPATH aims to build upon current developments in molecular imaging by creating an academic-industrial training and mobility network for the next revolution of imaging technology. Molecular in vivo imaging is a fertile area which combines expertise, state-of-art equipment and many disciplines and inter-sector work environments. Our goal is to better understand brain diseases and develop new preclinical imaging strategies. We believe optical imaging in particular represents a technology that has the potential to exploit further our knowledge in this area. Our main objective is to train a new generation of medical imaging scientists who, within the next 10-15 years, will bring optical brain imaging to the clinic. Indeed, it is envisaged that in the future optical imaging will be implemented as the fourth clinical modality in conjunction with the three already established clinical imaging techniques of Magnetic Resonance Imaging (MRI), X-ray Computed Tomography (CT) and Positron Emission Tomography (PET). Molecular in vivo neuro-imaging is rather underdeveloped, with its challenges specific to working on the brain, compared with other organs. Optical imaging can potentially play an important role in the multimodal orchestra together with MRI, PET and CT. Light can be used to measure functional aspects of the brain by either intrinsic monitoring of physiological changes, e.g. fluorescence, absorption, or by external contrast such as the use of fluorescence probes. Importantly, optical imaging is generally non-invasive and the equipment needed for such measurements are of low cost. A final unmet need is to integrate the different imaging modalities so that complementary information can be obtained from each modality. BRAINPATH will address this need and provide novel opportunities for treating important brain diseases. We will exploit this potential through transfer of knowledge between disciplines and sectors through training a next generation of imaging scientists.'